Cargando…
A phase I/Ib study of OTSGC-A24 combined peptide vaccine in advanced gastric cancer
BACKGROUND: We conducted a phase I/Ib, open-label, single-arm trial to assess the safety, tolerability and optimal scheduling regimen of OTSGC-A24 cancer vaccine in patients with advanced gastric cancer. METHODS: Patients with advanced gastric cancer with HLA-A*24:02 haplotype were included in this...
Autores principales: | Sundar, Raghav, Rha, Sun Young, Yamaue, Hiroki, Katsuda, Masahiro, Kono, Koji, Kim, Hyo Song, Kim, Chan, Mimura, Kousaku, Kua, Ley-Fang, Yong, Wei Peng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5870101/ https://www.ncbi.nlm.nih.gov/pubmed/29587677 http://dx.doi.org/10.1186/s12885-018-4234-8 |
Ejemplares similares
-
UGT1A6 Polymorphisms Modulated Lung Cancer Risk in a Chinese Population
por: Kua, Ley-Fang, et al.
Publicado: (2012) -
Immunogenic tumor cell death induced by chemoradiotherapy in a clinical setting
por: Kono, Koji, et al.
Publicado: (2013) -
Inhibition of mitogen-activated protein kinase pathway can induce upregulation of human leukocyte antigen class I without PD-L1-upregulation in contrast to interferon-γ treatment
por: Mimura, Kousaku, et al.
Publicado: (2014) -
Robotic radical lymphadenectomy without touching the pancreas during gastrectomy for gastric cancer
por: Ojima, Toshiyasu, et al.
Publicado: (2019) -
PD‐L1 expression is mainly regulated by interferon gamma associated with JAK‐STAT pathway in gastric cancer
por: Mimura, Kousaku, et al.
Publicado: (2017)